510(k) Report

510(k) · Cleared

Cleared

Rubicor Magic Breast Biopsy Device, Model 31537

K071048510(k) SpecialCleared May 15, 200732-day reviewClass II21 CFR 876.1075

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Rubicor Medical, Inc. · KNW Instrument, Biopsy

Cleared on May 15, 2007 as substantially equivalent to K053151 (Rubicor Medical, Inc., 2005) after a 32-day review. Its family tree reaches back 6 generations to 2001. 1 later device descends from it.

Decided
May 15, 2007
Review
32 days
Class
Class II
Product code
KNW
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K003528 (2001). 11 ancestors in all, the oldest K970565 (1997). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor1999: 1 other ancestor2001: 2 other ancestors1997: 1 other ancestor2014: 1 descendant clearedK003528 · Sanarus Core Tissue Biopsy System · Endocare, Inc. · 2001×2: 2 generations cleared close together, K021137 (2002), K022879 (2002) K032506 · Sanarus Centrica II Rotational Core Biopsy System · Sanarus Medical, Inc. · 2003K042136 · Sanarus Cassi Rotational Core Biopsy System · Sanarus Medical, Inc. · 2004K053151 · Rubicor Magic Breast Biopsy Device · Rubicor Medical, Inc. · 20051995200020052010201520202025
  1. Root · 6 generations backK003528 Sanarus Core Tissue Biopsy SystemEndocare, Inc. · 2001
  2. 5 generations backK021137 Sanarus Centrica Core Tissue Biopsy SystemSanarus Medical, Inc. · 2002
  3. 4 generations backK022879 Modification to Sanarus Centrica Core Tissue BiopsySanarus Medical, Inc. · 2002 · Recalled
  4. 3 generations backK032506 Sanarus Centrica II Rotational Core Biopsy SystemSanarus Medical, Inc. · 2003
  5. 2 generations backK042136 Sanarus Cassi Rotational Core Biopsy SystemSanarus Medical, Inc. · 2004
  6. 1 generation backK053151 Rubicor Magic Breast Biopsy DeviceRubicor Medical, Inc. · 2005
  7. This deviceK071048 Rubicor Magic Breast Biopsy Device, Model 31537Rubicor Medical, Inc. · 2007
  8. Descendant · cites it directly · 0 of its ownK133702 Presto Breast Biopsy DeviceSontina Medical, LLC · 2014

Most influential descendants

Showing 1 of 1 · See all
  • K133702Presto Breast Biopsy DeviceSontina Medical, LLC · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K003528Sanarus Core Tissue Biopsy SystemEndocare, Inc.2001—
−5K021137Sanarus Centrica Core Tissue Biopsy SystemSanarus Medical, Inc.2002—
−4K022879Modification to Sanarus Centrica Core Tissue BiopsySanarus Medical, Inc.20021
−3K032506Sanarus Centrica II Rotational Core Biopsy SystemSanarus Medical, Inc.2003—
−2K042136Sanarus Cassi Rotational Core Biopsy SystemSanarus Medical, Inc.2004—
−1K053151Rubicor Magic Breast Biopsy DeviceRubicor Medical, Inc.2005—
0 (this device)K071048Rubicor Magic Breast Biopsy Device, Model 31537Rubicor Medical, Inc.2007—
+1K133702Presto Breast Biopsy DeviceSontina Medical, LLC2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
199910
200120
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
FIG. 1 — Lineage of K071048, 2001–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KNW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KNW device

  1. #1 K260572 Marrow Marxmanscore 14.5 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053151Rubicor Magic Breast Biopsy Device
Summary page 1
…Equivalent Device: The subject device and accessory are substantially equivalent in intended use and/or method of operation to the Rubicor Magic TM Breast Biopsy Device (K053151) Intended Use: The Rubicor Breast Biopsy Device is intended for diagnostic sampling of breast tissue during breast biopsy proced…
Rubicor Medical, Inc.2005—

Also cleared against K053151: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K133702Presto Breast Biopsy DeviceSontina Medical, LLC20140

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 3 companies; a new generation was cleared every 1.1 years on median.
  • 2 of the 11 ancestors have a recall of any class.
  • Of its descendants, K133702 (Sontina Medical, LLC, 2014) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K053151.

How does its category compare?

All KNW devices

KNW Instrument, Biopsy: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · KNW

12in 2025

2007: 62008: 42009: 62010: 32011: 102012: 72013: 32014: 82015: 102016: 92017: 82018: 72019: 52020: 82021: 92022: 82023: 72024: 52025: 122026 (partial year): 7
2007high 12 (2025) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KNW

178in 2025

2007: 94 days median2008: 53 days median2009: 35 days median2010: 57 days median2011: 64 days median2012: 94 days median2013: 100 days median2014: 95 days median2015: 106 days median2016: 127 days median2017: 90 days median2018: 71 days median2019: 94 days median2020: 92 days median2021: 54 days median2022: 203 days median2023: 164 days median2024: 114 days median2025: 178 days median2026 (partial year): 29 days median
2007high 203 (2022) · low 35 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KNW

1in 2024

2007: 12008: 72009: 32010: 22011: 52012: 12013: 1, 1 Class I2014: 32016: 52017: 12019: 42021: 32022: 32023: 22024: 12026 (partial year): 4, 3 Class I
2007high 7 (2008) · low 0 (2015)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · KNW

1,667in 2025

2007: 7662008: 3632009: 3512010: 1622011: 672012: 932013: 982014: 1932015: 5912016: 2972017: 7602018: 1,0122019: 4,1952020: 5,1202021: 1,0202022: 5352023: 9312024: 1,2832025: 1,667
2007high 5,120 (2020) · low 67 (2011)2025

MAUDE reports naming product code KNW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076941766
20084537363
20096353351
20103572162
20111064567
2012794193
201331001 (1)98
20148953193
2015101060591
201691275297
20178901760
201877101,012
201959444,195
202089205,120
202195431,020
202282033535
202371642931
2024511411,283
20251217801,667
20267294 (3)—

What is it indicated for?

The Rubicor Breast Biopsy Device is intended for diagnostic sampling of breast tissue during breast biopsy procedures. It is to be used for diagnostic purposes only and is not intended for therapeutic uses. The Rubicor Breast Biopsy Device is indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. It is designed to provide breast tissue for histologic examination with partial or complete removal of the imaged…

Read the full statement (133 words)

The Rubicor Breast Biopsy Device is intended for diagnostic sampling of breast tissue during breast biopsy procedures. It is to be used for diagnostic purposes only and is not intended for therapeutic uses.

The Rubicor Breast Biopsy Device is indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. It is designed to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. The extent of histologic abnormality cannot be reliably determined from its mammographic appearance. Therefore, the extent of removal of the imaged evidence of an abnormality does not predict the extent of removal of a histologic abnormality (e.g., malignancy). When the sampled abnormality is not histologically benign, it is essential that the tissue margins be examined for completeness of removal using standard surgical procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071048: Rubicor Magic Breast Biopsy Device, Model 31537.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071048

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026